Below is the information acquired on MITSUBISHI CHEMICAL HOLDINGS CORPORATION, which is not yet included in our research perimeter.

To request an evaluation of this company and its inclusion in the OpenCorporation Ranking or if you have additional, different and more updated data than what is published in this OpenCorporation company card, please write to so that our team may take it in account.

Last update 31 March 2022

Description of economic activities

Manufacture of other chemical products nec (NACE2 2059)

This company is a holding firm that, through its subsidiaries, is engaged in the production and sale of various chemicals and healthcare products primarily in Japan. It was founded jointly in 1934 by Mitsubishi Chemical Corporation and Mitsubishi Pharma Corporation. It conducts business from its registered head office which is strategically located in Tokyo, Japan.As a holding firm, the company primarily provides financial support and control function for the board, and is responsible for managing the group and its overall legal structure, tax planning, financial and equity structures. The company operates in four segments: Petrochemicals, Performance Products, Functional Products, Health Care, and Services. Furthermore, Petrochemicals segment provides various polymers, monomers, and basic chemicals, including purified terephthalic acid, polypropylene, polycarbonate/phenol chain, polytetramethylene ether glycol, 1,4-butandiol, and other derivatives. Performance Products segment offers optical recording media, printing supplies, display materials, Li-ion battery materials, carbon products, environment-related materials/services, active pharmaceutical ingredient, and food ingredients. Functional Products segment provides food packaging materials, polyester films, carbon fiber, alumina fiber, civil engineering materials, construction materials, agricultural materials, and plastic pipes. Health Care segment engages in the research, development, and manufacture of pharmaceuticals in neuropsychiatry, circulatory system, and metabolism. It offers RADICUT, an ethical neuroprotective agent and ANPLAG, an antiplatelet agent. This segment also provides support services for drug discovery. Services segment engages in environmental analysis, investigation, and assessment; investigation, consulting, publication, informational services, and agency services; real estate, insurance agency, and office services; hotel business construction and maintenance of electrical measuring instruments; engineering and plant construction; logistics services; resin compounds, and computer systems and software development; recruiting and job consulting; research and technology development; and education and training.

  • Japan (JP)
  • Company type: Corporate
  • Parent company: N/A
  • Chief Executive Officer (CEO): Dr Yoshimitsu Kobayashi
  • CEO Total remuneration: N/A
  • Website:

Financial data

Number of employees


Revenue 1






1 numbers are in millions

  • RepRisk Indicator (last month):  21

Social dialog

  • Transnational Corporate Agreement (TCA): N/A
  • Global Framework Agreement (GFA): N/A
  • Societas Europaea (SE): N/A
  • Bangladesh Accord: N/A

European Works Councils

  • EWC: N/A

Standards and certifications

Global Reporting Initiative certification

  • Global Reporting Initiative standards: N/A
  • Global Reporting Initiative GRI G4: N/A

Other company declarations

  • Corporate Social Responsability:
  • Accessibility: N/A


  • Training policy: N/A
  • Policy to protect the right to health and safety in the workplaces where the company operates: N/A
  • Policy to protect the right to health and safety in the workplaces in the supply chain: N/A
  • Diversity policy: N/A

Universal declarations

Declarations and treaties recognised by the country where the company has its registered office

  • Universal Declaration of Human Rights:
  • European Convention on Human Rights (ECHR):
  • Charter of Fundamental Rights of CDFL Workers (Strasbourg Charter 1989):
  • Charter of Fundamental Rights of the European Union EU CFR (Nice Charter 2000):
  • Treaty on the Functioning of the European Union TFEU:
  • Registered office in an OECD country:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Directives applied in the company offices in EU 27

  • D. 80/987/EEC: N/A
  • D. 89/391/EEC: N/A
  • D. 98/59/EC: N/A
  • D. 2000/43/EC: N/A
  • D. 2000/78/EC: N/A
  • D. 2001/23/EC: N/A
  • Council D. 2001/86/EC: N/A
  • D. 2002/14/EC: N/A
  • D. 2002/73/EC: N/A
  • Council D. 2003/72/EC: N/A
  • EP and Council D. 2005/56/EC: N/A
  • D. 2009/38/EC: N/A
  • D. 2004/25/EC: N/A
  • D. 2011/35/EU: N/A

Presence in main rankings

  • Global 100 Most Sustainable Corporations: N/A
  • Global CSR Rep Trak 100: N/A
  • BrandZ Top 100 Most Valuable US Brands: N/A
  • The Worlds Best Multinational Workplaces: N/A
  • The Gartner Supply Chain Top 25: N/A
  • The Worlds Most Innovative Companies: N/A
  • The Diversity Inc Top 50 Companies: N/A
  • Best Global Websites: N/A
  • Green Ranking Global Top 500:
  • Green Ranking Global Top 100: N/A

Reference trade unions

Latest news about mitsubishi chemical holdings corporation

24 September 2021 - 14:40

Puglia. Lavoro agli sfruttati dei campi, l’Ong Oxfam premia la multinazionale

Il riconoscimento a Princes Industrie Alimentari che a Foggia ha assunto nove giovani immigrati. Il contributo della Caritas di Foggia